GK Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
SRIM
SAM
GA
QI
AA
OFA
PM
PFS
AIP
GK Wealth Management's NVO Position: Q2 2026 in Review
GK Wealth Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 6,182 shares worth $296K. The stake represents 0.16% of the portfolio and ranks #160 among its holdings. This is a return to the name: GK Wealth Management previously reported a position in NVO as recently as Q3 2025.
GK Wealth Management first reported a position in NVO in Q4 2024 and has held it in 4 quarters since. The position peaked at $338K in Q3 2025. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- GK Wealth Management held 6,182 shares of Novo Nordisk worth $296K as of Q2 2026.
- Novo Nordisk was a new GK Wealth Management position in Q2 2026.
- Novo Nordisk made up 0.16% of GK Wealth Management's portfolio in Q2 2026, its #160 holding.
- GK Wealth Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 4 quarters since.
- GK Wealth Management's Novo Nordisk position peaked at $338K in Q3 2025.
- 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on GK Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.